FAOSX
Price
$39.07
Change
+$0.24 (+0.62%)
Updated
Oct 8 closing price
Net Assets
467.47M
RERBX
Price
$61.83
Change
+$0.49 (+0.80%)
Updated
Oct 8 closing price
Net Assets
137.54B
Interact to see
Advertisement

FAOSX vs RERBX

Header iconFAOSX vs RERBX Comparison
Open Charts FAOSX vs RERBXBanner chart's image
Fidelity Advisor Overseas Z
Price$39.07
Change+$0.24 (+0.62%)
VolumeN/A
Net Assets467.47M
American Funds EUPAC R2
Price$61.83
Change+$0.49 (+0.80%)
VolumeN/A
Net Assets137.54B
FAOSX vs RERBX Comparison Chart in %
View a ticker or compare two or three
VS
FAOSX vs. RERBX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAOSX is a StrongBuy and RERBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 138B vs. FAOSX (467M). FAOSX pays higher dividends than RERBX: FAOSX (1.49) vs RERBX (0.24). FAOSX was incepted earlier than RERBX: FAOSX (9 years) vs RERBX (23 years). RERBX (1.56) is less costly to investors than FAOSX (0.64). RERBX (35.00) and FAOSX (34.00) have comparable annual turnover. FAOSX has a lower initial minimum investment than RERBX: FAOSX (0) vs RERBX (250). FAOSX annual gain was more profitable for investors over the last year : 12.76 vs. RERBX (10.25). FAOSX return over 5 years is better than : 48.03 vs. RERBX (9.41).
FAOSXRERBXFAOSX / RERBX
Total Expense Ratio0.641.5641%
Annual Report Gross Expense Ratio0.641.5641%
Fund Existence9 years23 years-
Gain YTD20.85321.59397%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets467M138B0%
Annual Yield % from dividends1.490.24629%
Returns for 1 year12.7610.25124%
Returns for 3 years75.4247.60158%
Returns for 5 years48.039.41510%
Returns for 10 yearsN/A37.49-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.503.19
+11.68%
Stoke Therapeutics
AAME2.920.14
+5.22%
Atlantic American Corp
FIVE153.765.26
+3.54%
Five Below
QETAU10.84N/A
N/A
Quetta Acquisition Corp
TONX6.33-0.05
-0.71%
TON Strategy Company